Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127882551 | 12788255 | 1 | I | 20160504 | 20160920 | 20160928 | 20160928 | EXP | US-ASTRAZENECA-2016SF01081 | ASTRAZENECA | 28963.00 | DY | F | Y | 57.20000 | KG | 20160928 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127882551 | 12788255 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | Y | 20541 | 1 | MG | TABLET | QD | ||||||
| 127882551 | 12788255 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | 20 | MG | CAPSULE | QD | ||||||
| 127882551 | 12788255 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 127882551 | 12788255 | 4 | SS | IBRANCE | PALBOCICLIB | 1 | Unknown | 0 | 125 | MG | QD | ||||||||
| 127882551 | 12788255 | 5 | C | LETROZOLE. | LETROZOLE | 1 | Oral | 0 | 2.5 | MG | TABLET | QD | |||||||
| 127882551 | 12788255 | 6 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 127882551 | 12788255 | 7 | C | CENTRUM | VITAMINS | 1 | Oral | 0.4-162-18 MG; 1 TABLET DAILY | 0 | TABLET | |||||||||
| 127882551 | 12788255 | 8 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | Oral | 0 | 70 | MG | TABLET | QD | |||||||
| 127882551 | 12788255 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLET | QD | |||||||
| 127882551 | 12788255 | 10 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127882551 | 12788255 | 4 | Breast cancer |
| 127882551 | 12788255 | 5 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127882551 | 12788255 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127882551 | 12788255 | Amnesia | |
| 127882551 | 12788255 | Breast cancer metastatic | |
| 127882551 | 12788255 | Cerumen impaction | |
| 127882551 | 12788255 | Dizziness | |
| 127882551 | 12788255 | Dyspnoea | |
| 127882551 | 12788255 | Fatigue | |
| 127882551 | 12788255 | Hypercholesterolaemia | |
| 127882551 | 12788255 | Metastases to bone | |
| 127882551 | 12788255 | Metastases to liver | |
| 127882551 | 12788255 | Metastases to lung | |
| 127882551 | 12788255 | Osteoporosis | |
| 127882551 | 12788255 | Pyrexia | |
| 127882551 | 12788255 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127882551 | 12788255 | 1 | 201410 | 0 | ||
| 127882551 | 12788255 | 4 | 201511 | 0 | ||
| 127882551 | 12788255 | 5 | 201511 | 0 | ||
| 127882551 | 12788255 | 6 | 20160128 | 0 |